Vicapsys Life Sciences Company Description

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product.

The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field.

It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.

The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017.

Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.

Vicapsys Life Sciences, Inc.

Country	United States
Founded	1997
Industry	Biotechnology
Sector	Healthcare
Employees	2
CEO	Federico Pier

Contact Details

Address: 7778 Mcginnis Ferry Road Suwanee, Florida 30024 United States
Phone	972 891 8033
Website	vicapsys.com

Stock Details

Ticker Symbol	VICP
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US92560A1060
SIC Code	2836

Key Executives

Name	Position
Federico Pier	Chief Executive Officer
Jeffery Wright	Chief Financial Officer